Makers of Zicam, Swisse Wellness headline new CRN members
The Council for Responsible Nutrition on Tuesday announced six new companies have joined the association’s membership ranks including voting members Matrixx Initiatives, NattoPharma, SolMic Research and Swisse Wellness. In addition, associate members Carter Regulatory Group and M. Vicinanzo Consulting have joined the association.
Matrixx Initiatives manufactures and markets Zicam brand homeopathic and allopathic OTC products. The company’s products include Zicam Cold Remedy Nasal Spray and Swab, Zicam Cold Remedy Rapidmelts, Zicam Cold Remedy Oral Mist and Zicam Cold Remedy Medicated Fruit Drops. Matrixx products also include Zicam Cold Remedy Relief for Kids, Zicam Allergy Relief Spray and Swab, Zicam Extreme Congestion Relief and Zicam Intense Sinus Relief.
NattoPharma, based in Norway, is involved in vitamin K2 research and development and is the exclusive international supplier of MenaQ7 Vitamin K2 as MK-7. The company has a multi-year research and development program to substantiate and discover the health benefits of vitamin K2 for applications in the marketplace for functional food and dietary supplements. With a global presence, the company established its North American subsidiary, NattoPharma USA in Edison, N.J.
SolMic Research Germany is a private company that focuses on the development of a broad range of nutraceuticals, cosmeceuticals and pharmaceuticals. The company’s technology is actively enhancing the uptake of fat soluble ingredients by rendering them water-insoluble ingredients. SolMic Research currently sells in Europe and just started selling dietary supplements and technology for dietary supplements in the U.S. and Canada.
Swisse Wellness is an Australian-based manufacturer of vitamin, herbal and mineral supplements, skincare and sports nutrition products. Part of the Hong Kong listed H&H Group, Swisse’s mission is to make people around the world happier and healthier, brought to life not only through its products, but also through a focus on advocating movement, nutrition and mindfulness.
Carter Regulatory Group is an international regulatory consulting firm specializing in regulatory solutions for companies of all sizes, while M. Vicinanzo Consulting provides regulatory direction and strategic solutions to corporate clients on developing and promoting dietary supplements, drugs, cosmetics and food products.
GSK Consumer Healthcare names chief marketing officer
GSK Consumer Healthcare on Monday name Amardeep Kahlon to the role of chief marketing officer and vice president of U.S. marketing.
Kahlon will report to Colin Mackenzie, region head of the Americas, and become a member of his leadership team.
“I’m thrilled to have Amardeep back on our team in the U.S. His familiarity with our market, customers and brand teams will help ensure a smooth transition and keep us on track to deliver our KPIs for Innovation, Performance and Trust,” Mackenzie said.
Kahlon was formerly the vice president and global business leader for cold and flu in the respiratory category, where he was responsible for the global delivery of programs and innovation to drive growth on the Theraflu brand concept.
During his time in the business, Kahlon led a digital acceleration program to drive new content in support of Theraflu innovations.
Ananda Professional launches new CBD oil for pharmacies
CYNTHIANA, Ky. — Ananda Professional, a wholly owned subsidiary of Ecofibre, recently announced the launch of a Cannabidiol (CBD) oil product line that’s available exclusively in U.S. independent pharmacies.
The line includes for oral use, a 300ml and 600ml tincture and a 30 and 60 count, 15ml soft gel, as well as a 125mg salve for topical use.
“Pharmacists are considered the most trusted healthcare professional,” stated chief revenue officer Chuck Schneider, “They are often the first stop for patients and consumers seeking information about prescription and over-the-counter treatments. Most importantly, they are best equipped as they have an understanding of a patient’s therapy regiment.”
Added Ecofibre’s CEO Eric Wang, “Vertical integration and full control of the manufacturing process ensures federal compliancy. Ananda Professional adheres to the strict government guidelines outlined by section 7606 of the 2014 Farm Bill and we proudly guarantee this. Our product is also cGMP (Current Good Manufacturing Processes) compliant, ensuring product consistency, purity and potency.”
The company is also working to bridge the knowledge gap and confusion about what hemp-derived CBD is and isn’t.
Both hemp and marijuana are members of the cannabis sativa family, but marijuana contains high levels of the psychoactive compound, THC. Hemp contains less than 0.3 percent THC and high levels of CBD, the non-psychoactive compound with a vast array of therapeutic potential, the company stated.
“The endocannabinoid system (ECS) present in all humans is responsible for a host of homeostasis activities, including immune response, inflammation, sleep/wake cycle regulation, and mood. ECS receptors are found extensively throughout the body; in the brain, the lymphatic system, the digestive system, the reproductive system and more. CBD influences activity within the ECS, upregulating our endogenous neurotransmitters to promote a variety of therapeutic responses,” explained Ananda Professional’s medical director Alex Capano,
Ananda Professional conducts free webinars to help educate pharmacists and their staff on the ECS, CBD’s safety and efficacy profile and how CBD helps patients suffering from pain, inflammation (arthritis), sleep disorders, anxiety and other conditions.
The company noted that pharmacists and executives will have the opportunity to speak directly with Ananda Professional at Cardinal’s RBC conference in San Diego, June 26 to 30, and the National Community Pharmacy Association convention this October in Boston.